News
April 2007
British Firm Develops Inhalable Viagra That Works In 60 Seconds
26 April 2007: A British biotechnology firm
has developed an inhaled version of Viagra, which works in mere 60 seconds.
The drug is known by its medical name VR004 and it get absorbed instantly
into the bloodstream through the lungs...Read
More...
U.S. Weight Loss Market To Reach $68 Billion By 2010
25 April 2007: The U.S. weight loss market
will continue to grow and will become a whopping $68.7 billion market
by 2010, according to Marketdata Enterprises, Inc...Read
More...
Around 20% Of Asian Men Suffer From Erectile Dysfunction
25 April 2007: Jude Selvaraj, Pfizer’s
medical adviser in Singapore and Malaysia, recently said that around 20
percent of Asian men suffer from erectile dysfunction disease...Read
More...
Viagra
Being Tested To Reduce Premature Births
19 April 2007: Viagra—the
drug that helped millions of men with erectile dysfunction, is undergoing
clinical trials to reduce premature births by helping babies stay longer
in the womb...Read
More...
Children With Otitis Media Have Higher BMI
18 April 2007: Children with otitis media
with effusion have 35 percent higher body mass index (BMI) than children
with no history of ear infection, said researchers...Read
More...
Spider
Venom May Replace Viagra As Erection Elixir
12 April 2007: Rambam Medical Center in
Haifa(Israel) hopes to bring glad tiding for men suffering from impotence,
and the start performers have eight legs...Read
More...
Maxigra On The
Market
05 April 2007: Maxigra, a Polish generic
equivalent of Viagra, went
on sale in pharmacies on 28 March, Krzysztof Jakubiak, PR director at
Polpharma, Maxigra’s manufacturer, confirmed to Pharma Poland News...Read
More...
Diet Pill Alli Likely To Be Available In Europe By 2008
03 April 2007: Diet pill Alli, which will
be available for sale in the US this summer, is likely to be available
in Europe by the end of next year...Read
More...
Sanofi's
Acomplia Wins Swiss Approval
03 April 2007: French drugmaker Sanofi-Aventis
said on Tuesday its anti-obesity drug Acomplia
had been approved in Switzerland for obese or overweight patients...Read
More...
|
